ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02428855
Brief Title: Phase II Trial of Dasatinib in Patients With Isocitrate Dehydrogenase (IDH)-Mutant Advanced Intrahepatic Cholangiocarcinoma

First Submitted : April 23, 2015
First Submitted that Met QC Criteria : April 28, 2015
First Posted : April 29, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : April 23, 2018
Last Update Posted : April 24, 2018